The FDA has accepted Bristol-Myers Squibb’s application to get its star oncology treatment approved for lung cancer, setting up a speedy approval and putting the company first in line among drug developers at work in a blockbuster field.

…read more

Source: Bristol-Myers takes a big step in its PD-1 lung cancer race with Merck